Nagpur: Cardiological Society of India Vidarbha Chapter (CSI) held “The Big Debate” on “Hyponatremia in Heart Failure” on 17th October 2014 at Hotel Centre Point, Ramdaspeth.
Low levels of important ion of Sodium ( Na+) is a commonest finding in Intensive Care Units. Lots of struggle is required to bring it near normal and is always a big challenge for physicians treating acute sick hospitalaised people. The casues could be vary be varying from dilutional hyponatremia ( hypervolemic, euvolemic) to depletional hyponatremia. Lately a promising USA FDA approved drug “Vaptrans” as arrived in the market. There are many dilemma in minds of physicians attending heart failure , hence this big debate, infromed Dr. Shantanu Sengupta President CSI, in his opening welcome speech.
Dr. Jay Deshmkuh talked for on Role of Vaptans while Dr. Anil Jawahirani spoke against the motion. Both the speakers put forth their points and counter points and debated positive and negative effects. Usefulness and no role at all, considering cost, altanatives and safety.
In conclusion, although it may not prolong the life, but in view of improved quality of life, the medicine has definite use if judiciously used in patients of heart failure, opined Dr. R. G. Salkar & Dr. Sanjay Jain who chaired the debate session.
Dr. Pavan Agrawal Secretary, proposed the vote of thanks. Sun Pharma has exetended unconditional education grant for the event. Large number of physicians and cardiologists atten ed the debate.
